Pulmonary Arterial Hypertension (PAH) Market Boosted by Recently-approved Drugs James Conner Inverted Jersey , to Reach US$5.19 bn Health Articles | March 31, 2016
Global Pulmonary Arterial Hypertension (PAH) Market was valued at USD 4.04 billion in 2013 and is expected to grow at a CAGR of 2.3% from 2014 to 2020, to reach an estimated value of USD 5.19 billion in 2020.
Pulmonary arterial hypertension is when the blood pressure inside the small arteries within the lungs increases. PAH can cause swelling of legs, fainting, dizziness, and shortness of breath, among other more serious symptoms. One of the biggest problems that a patient with PAH suffers is an extremely low tolerance to exercise. PAH can escalate into pulmonary vascular resistance and cause the failure of the right ventricle.
According to the report JuJu Smith-Schuster Inverted Jersey , the primary driver for the聽global PAH market is the list of newly-approved drugs and medical products aimed at treating PAH. A large number of medical products are already approved, while more are still in the pipeline. Another factor promoting the growth of the global PAH market is the increasing number of leaps taken in research and development efforts, aided by government policies and other initiatives.
The report provides a segmented analysis of the global PAH market. These segments are sorted within the categories of drug class and geography. The report also provides an extensive analysis of the pipeline drugs in the global PAH market.
In terms of drug class, the global PAH market is segmented into soluble guanylate cyclase (sGC) stimulators, phosphodiesterase-5 (PDE-5) inhibitors, endothelin receptor antagonists (ERAs), and prostacyclin and prostacyclin analogs. Of these T. J. Watt Inverted Jersey , the report’s authors have put the prostacyclin and prostacyclin analogs segment ahead of the ERA segment, which means that the segment will lead the global PAH market by 2023, surpassing the current leader, ERAs.
The report’s geographical segmentation of the global PAH market reveals Asia Pacific to be the fastest-growing region for the given forecast period. The growth rate of this region is attributed to major opportunities that will be found in Australia, New Zealand, Japan, China Terrell Edmunds Inverted Jersey , and India. Enterprises operating in these regions could take advantage of these opportunities and increase their profits and presence in the market.
The report, however, states one of the major restraints on the global PAH market as the challenges faced by the Rest of the World PAH market. The report’s study shows that most of the nations in the Rest of the World region possess a low level of awareness of this market’s products. Therefore, this region is showing a much slower growth rate when compared to the regions of North America or Europe.
The key players in the global pulmonary arterial hypertension market are United Therapeutics Corp., Novartis International AG, Pfizer Inc., GlaxoSmithKline plc Jerome Bettis Inverted Jersey , Bayer HealthCare, Gilead Sciences Inc., and Actelion Pharmaceuticals Ltd.
Key segments of the Global Pulmonary Arterial Hypertension (PAH) Market
Global Pulmonary Arterial Hypertension Market, by Drug Class Prostacyclin and Prostacyclin Analogs Endothelin Receptor Antagonists (ERAs) Phosphodiesterase-5 (PDE-5) Inhibitors Soluble Guanylate Cyclase (sGC) Stimulators
Pipeline Analysis: Pulmonary Arterial Hypertension Market Early-stage Drug Candidates (Phase I & Phase II) Late-stage Drug Candidates (Phase III & Registration Phase)
Download Free Sample Report Brochure: >
Laboratory Information System Market - On-premise Technology and Cloud Based Technology Health Articles | July 11, 2016
Transparency Market Research Report Added "Laboratory Information System Market - Global Industry Analysis, Size, Share Zach Gentry Jersey , Growth, Trends and Forecast, 2013 - 2019"
A research report on the global laboratory information system market, published by Transparency Market Research (TMR), estimates the market to rise at a CAGR of 7.70% during the period from 2013 and 2019. In 2013, the market reached US$1,381.4 bn and it is expected to attain a value of US$2 Benny Snell Jr. Jersey ,158.0 bn by the end of the forecast research report is titled “Laboratory Information System Market - Global Industry Analysis, Size,